CN100391526C - Powder comprising oyster and king solomonseal root - Google Patents
Powder comprising oyster and king solomonseal root Download PDFInfo
- Publication number
- CN100391526C CN100391526C CNB2005100419177A CN200510041917A CN100391526C CN 100391526 C CN100391526 C CN 100391526C CN B2005100419177 A CNB2005100419177 A CN B2005100419177A CN 200510041917 A CN200510041917 A CN 200510041917A CN 100391526 C CN100391526 C CN 100391526C
- Authority
- CN
- China
- Prior art keywords
- fructus
- treatment
- present
- medicine
- rhizoma polygonati
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to an oral administration health-care product for adjunctive therapy of calvities. The product comprises the following components: 7 to 25 wt% of solomonseal rhizome, 7 to 25 wt% of mulberry, 5 to 20 wt% of wolfberry fruit, 5 to 20 wt% of polygonatum, 8 to 40 wt% of oyster, 2 to 15 wt% of fructus and 5 to 20 wt% of raspberry. The present invention solves the technical problems of poor product treatment effect, no individuation treatment or untoward reaction of treating alopecia in the background technology.
Description
One, technical field
The present invention relates to a kind of health product, especially a kind of Orally taken health article that is used for the auxiliary treatment alopecia.
Two, background technology
Since the quickening of modern life rhythm, the sharp increase of operating pressure, and various hair illness such as alopecia have brought increasing puzzlement for modern's life.The product for the treatment of alopecia in the market mostly is cosmetics, care appliance, and wherein Dai Biao product is the refreshing comb of ZHANGGUANG 101, newborn black pigment used by women in ancient times to paint their eyebrows hair growth promoting, and all there is following shortcoming in this series products:
1, therapeutic effect is poor.Because above two series products all are to be coated with by human external to touch or the mode of part massage is treated alopecia, can not enter human body, can not fundamentally improve the natural on-off cycles of hair growth environment, therefore can only cure the symptoms, not the disease, control outer do not control in, so therapeutic effect is very little.
2, no personalized treatment.More than two series products can not carry out meticulous dialectical allotment, can not accomplish to shoot the arrow at the target at dissimilar patients.
3, untoward reaction is arranged.Untoward reaction such as can occur swelling and ache when using on the hair of allergic skin body constitution.
Three, summary of the invention
The product therapeutic effect that the invention solves the treatment alopecia in the background technology is poor, do not have personalized treatment and the technical problem of untoward reaction is arranged.
Technical scheme of the present invention is: the present invention is a kind of medicine of auxiliary treatment Liver and kidney two deficient syndrome alopecias, and its special character is: the percentage by weight of the medicine of described auxiliary treatment Liver and kidney two deficient syndrome alopecias is formed and is comprised Rhizoma Polygonati 7~25%, Fructus Mori 7~25%, Fructus Lycii 5~20%, Rhizoma Polygonati Odorati 5~20%, Concha Ostreae 8~40%, Fructus Alpiniae Oxyphyllae 2~15%, Fructus Rubi 5~20%.
The medicine of above-mentioned auxiliary treatment Liver and kidney two deficient syndrome alopecias also includes Thallus Laminariae (Thallus Eckloniae) 0.1~20%, Radix Glycyrrhizae 1~15%.
The present invention faces the card experience according to the traditional Chinese medical science several thousand, and find in the medical practice of the clinical experience of two more than ten years and treatment alopecia, the people is an integral body, hair is a part of human body, if the human physiological functions imbalance, the natural on-off cycles of hair growth environment is destroyed, and then hair comes off in a large number, hair is sparse, even bald.Therefore the present invention is according to the basic theories of the traditional Chinese medical science " organic conception ", " treatment must aim at the pathogenesis of disease ", " dialectical opinion is controlled ", simultaneously according to the function of human body of putting down in writing in Compendium of Material Medica, Shennong's Herbal, " Treatise on Dietetic Therapy " of improvement that has, the integration of edible and medicinal herbs product that can eat again, the file of the integration of edible and medicinal herbs of announcing according to health ministry, develop this health food, so the present invention has the following advantages:
1, integration of edible and medicinal herbs, therapeutic effect is good.The present invention looses in conjunction with hair growth accelerating to use together, by the oral function of human body of adjusting, improves the natural on-off cycles of hair growth environment, but treating both the principal and secondary aspects of a disease.
2, can carry out personalized treatment.The present invention can carry out meticulous dialectical allotment according to patient's different body constitution, symptom, looses in conjunction with hair growth accelerating and uses together, accomplishes personalized treatment; The present invention is mainly used in having a dizzy spell due to the deficiency of the liver and kindey, soreness of the waist and knees, tinnitus, insomnia and dreamful sleep, night sweat, seminal emission, clear urine in large amounts, frequent urination at night, and various alopecia Liver and kidney two void such as deep-thready pulse lay particular stress on the auxiliary treatment of disease type.
3, had no side effect, filled up the blank of the health food of treatment alopecia.
Four, the specific embodiment
It is monarch drug that the present invention selects Rhizoma Polygonati, Fructus Mori, Fructus Lycii, Rhizoma Polygonati Odorati enriching yin and nourishing kidney; The Concha Ostreae suppressing the hyperactive liver and subsiding YANG, arresting sweating, Fructus Alpiniae Oxyphyllae, Fructus Rubi arresting seminal emission reducing urination are ministerial drug.
In order to obtain optimum curative effect, the present invention also can add Thallus Laminariae (Thallus Eckloniae), Radix Glycyrrhizae on the basis of said components, and the capable water of Thallus Laminariae (Thallus Eckloniae) is in case astringent therapy is excessive, and the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is a messenger drug.
The consumption of component of the present invention is also groped to sum up to draw through the inventor in a large number, and each amounts of components is for all to have good efficacy in following weight percentage ranges:
Percentage by weight consumption of the present invention is: Rhizoma Polygonati 7~25%, Fructus Mori 7~25%, Fructus Lycii 5~20%, Rhizoma Polygonati Odorati 5~20%, Concha Ostreae 8~40%, Fructus Alpiniae Oxyphyllae 2~15%, Fructus Rubi 5~20%.
Percentage by weight consumption of the present invention can also be Rhizoma Polygonati 7~25%, Fructus Mori 7~25%, Fructus Lycii 5~20%, Rhizoma Polygonati Odorati 5~20%, Concha Ostreae 8~40%, Fructus Alpiniae Oxyphyllae 2~15%, Fructus Rubi 5~20%, Thallus Laminariae (Thallus Eckloniae) 0.1~20%, Radix Glycyrrhizae 1~15%.
Below be concrete proportioning example of the present invention (is unit with the percentage by weight):
Production technology of the present invention following (production technology with health promoting beverage is an example):
1) each raw material is taken by weighing by proportioning;
2) raw material pulverizing that proportioning is good, sieve;
3) hybrid packed the getting final product of raw material after will sieving.
Clinical comparison experimental result of the present invention is as follows:
Lay particular stress on disease type alopecia patient at diffusing primary symptom Liver and kidney two void of hair growth accelerating, with every group 50 example, carry out 3 groups of treatments, curative effect is as follows:
Example one, matched group: the treatment of loosing of the oral hair growth accelerating of patient, every day twice, each 5 grams, with 4 weeks be a course of treatment, after 8 courses of treatment, 15 examples of fully recovering, 30 examples, invalid 5 examples take a turn for the better.
Example two, treatment group one: patient's oral hair growth accelerating of while looses and component is the medicine of the auxiliary treatment Liver and kidney two deficient syndrome alopecias of Rhizoma Polygonati, Fructus Mori, Fructus Lycii, Rhizoma Polygonati Odorati, Concha Ostreae, Fructus Alpiniae Oxyphyllae, Fructus Rubi, twice of every day, each hair growth accelerating looses and the medicine of auxiliary treatment Liver and kidney two deficient syndrome alopecias respectively 5 restrains, with 4 weeks be a course of treatment, after 8 courses of treatment, 28 examples of fully recovering, improvement 17 examples, invalid 5 examples.
Treatment group two: patient's oral hair growth accelerating of while looses and component is the medicine of the auxiliary treatment Liver and kidney two deficient syndrome alopecias of Rhizoma Polygonati, Fructus Mori, Fructus Lycii, Rhizoma Polygonati Odorati, Concha Ostreae, Fructus Alpiniae Oxyphyllae, Fructus Rubi, Thallus Laminariae (Thallus Eckloniae), Radix Glycyrrhizae, twice of every day, each hair growth accelerating looses and the medicine of auxiliary treatment Liver and kidney two deficient syndrome alopecias respectively 5 restrains, with 4 weeks be a course of treatment, after 8 courses of treatment, 30 examples of fully recovering, improvement 16 examples, invalid 4 examples.
The above hair growth accelerating looses and is disclosed Chinese patent medicine preparation in the application for a patent for invention prospectus of publication number CN1504210A, and it is Rhizoma Atractylodis 1%20% that its percentage by weight is formed; Rhizoma Atractylodis Macrocephalae (parched) 1%-12%; Radix Codonopsis 3%-30%; Radix Angelicae Sinensis 2%-27%; Rhizoma Chuanxiong 1%-18%; Radix Bupleuri 3%-25%; Radix Astragali 1%-20%; Radix Polygoni Multiflori Preparata 0.5%-10%; Clear Rhizoma Pinelliae Preparata 0.5%-2%; Polyporus 1%-10%; Poria 0.5%-10%; Semen Plantaginis 0.5%-10%; Rhizoma Alismatis 0.5%-10%; Semen Coicis 3%-30%; Flos Carthami 3%-30%; Radix Saposhnikoviae 0.1%-10%; Radix Paeoniae Rubra 3%-30%; Radix Salviae Miltiorrhizae 3%-30%; Semen Persicae 3%-30%; Pericarpium Citri Reticulatae 5%-30%; Fructus Aurantii 1%-10%; Herba Pogostemonis 3%-30%; Herba Eupatorii 3%30%; Herba Lycopi 3%-30%; Rhizoma Corydalis 3%-30%; Pericarpium Citri Reticulatae Viride 1%-30%; Cortex Magnoliae Officinalis 0.5%-20%; Radix Angelicae Dahuricae 1%-10%; Radix Platycodonis 3%-30%.
Claims (2)
1. the medicine of auxiliary treatment Liver and kidney two deficient syndrome alopecias is characterized in that: the percentage by weight of described medicine is formed and is comprised Rhizoma Polygonati 7~25%, Fructus Mori 7~25%, Fructus Lycii 5~20%, Rhizoma Polygonati Odorati 5~20%, Concha Ostreae 8~40%, Fructus Alpiniae Oxyphyllae 2~15%, Fructus Rubi 5~20%.
2. medicine according to claim 1 is characterized in that: described medicine also includes Thallus Laminariae (Thallus Eckloniae) 0.1~20%, Radix Glycyrrhizae 1~15%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100419177A CN100391526C (en) | 2005-04-07 | 2005-04-07 | Powder comprising oyster and king solomonseal root |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100419177A CN100391526C (en) | 2005-04-07 | 2005-04-07 | Powder comprising oyster and king solomonseal root |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1843485A CN1843485A (en) | 2006-10-11 |
CN100391526C true CN100391526C (en) | 2008-06-04 |
Family
ID=37062471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100419177A Expired - Fee Related CN100391526C (en) | 2005-04-07 | 2005-04-07 | Powder comprising oyster and king solomonseal root |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100391526C (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102784346B (en) * | 2012-08-30 | 2015-08-26 | 黄美钦 | Rhizoma Polygonati Odorati Radix Glycyrrhizae oolong bagged tea and preparation method thereof |
CN104012947A (en) * | 2013-12-15 | 2014-09-03 | 胡安然 | Diet for conditioning kidney deficiency |
CN106606672A (en) * | 2016-11-25 | 2017-05-03 | 安徽邵氏华艾生物医疗电子科技有限公司 | Yin nourishing and kidney tonifying Chinese herbal granule and preparation method thereof |
CN111821376A (en) * | 2019-04-19 | 2020-10-27 | 河北环兴保健食品有限公司 | Chinese medicinal granule for promoting blood circulation and removing blood stasis, and its preparation method |
CN111671870A (en) * | 2020-07-01 | 2020-09-18 | 刘巧凤 | A pharmaceutical composition for treating genitourinary system and lower urinary tract diseases |
CN113413445B (en) * | 2021-06-28 | 2023-07-14 | 金牛区翔劲一类医疗器械经营部 | Composition and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582986A (en) * | 2004-06-08 | 2005-02-23 | 江保兵 | Hair growth liniment |
-
2005
- 2005-04-07 CN CNB2005100419177A patent/CN100391526C/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1582986A (en) * | 2004-06-08 | 2005-02-23 | 江保兵 | Hair growth liniment |
Also Published As
Publication number | Publication date |
---|---|
CN1843485A (en) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100536885C (en) | Medicine for treating phalacrosis and restoring hair | |
CN101711850B (en) | Traditional Chinese medicine composition for treating symptoms of myocardial ischemia, palpitation and severe palpitation and preparation method | |
CN101642540A (en) | Chinese patent medicine for tranquilizing and allaying excitement | |
CN101284073B (en) | Combination medicine for curing the hoary hair | |
CN102526663A (en) | Medicine for treating leukotrichia | |
CN103536758A (en) | Traditional Chinese medicinal composition for treating night sweat due to yin deficiency | |
CN100391526C (en) | Powder comprising oyster and king solomonseal root | |
CN102614442B (en) | Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis | |
CN101862411B (en) | Chinese medicinal composition for treating acne | |
CN101966319A (en) | Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof | |
CN100391518C (en) | Powder containing honeysuckle flower | |
CN104940773A (en) | Making method for kidney-strengthening liver-protecting blood-replenishing and qi-benefiting health care product | |
CN103356944A (en) | Chinese medicine composition for treating anemia | |
CN100391511C (en) | Peach kernel macrostem onion powder | |
CN105079437A (en) | Traditional Chinese medicine healthcare preparation used for prolonging life | |
CN105381420A (en) | Traditional Chinese medicine for treating fatty liver | |
CN100434111C (en) | Powder containing seed of spine date, licorice and wheat | |
CN100444885C (en) | Powder containing fingered citron and citron | |
CN106362120A (en) | Traditional Chinese medicine prescription for treating hyperglycemia and diabetes | |
CN100434110C (en) | Powder comprising mint and chrysanthemum | |
CN102552537A (en) | Chinese medicinal composition for treating qi and blood loss | |
CN102416146A (en) | Chinese medicinal composition for treating amenorrhea | |
CN106237221A (en) | A kind of benefiting QI and nourishing blood, the Chinese medicine composition of nourishing the liver and kidney | |
CN101461889A (en) | External therapy for mouth ulcer, toothache and furuncle of head and face | |
CN100434115C (en) | Powder containing tuckahoe, seed of gordon euryale, coix seed and lotus seed |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080604 Termination date: 20130407 |